Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2018

DrugPatentWatch Database Preview

Exela Pharma Scs Llc Company Profile

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCS LLC, and when can generic versions of EXELA PHARMA SCS LLC drugs launch?

EXELA PHARMA SCS LLC has eight approved drugs.

There is one US patent protecting EXELA PHARMA SCS LLC drugs.

Summary for Exela Pharma Scs Llc

US Patents:	1
Tradenames:	8
Ingredients:	8
NDAs:	8

Drugs and US Patents for Exela Pharma Scs Llc

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Exela Pharma Scs Llc	PANTOPRAZOLE SODIUM	pantoprazole sodium	POWDER;IV (INFUSION)	209463-001	Jun 30, 2017		RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Scs Llc	NIPRIDE RTU IN SODIUM CHLORIDE 0.9%	sodium nitroprusside	SOLUTION;IV (INFUSION)	209387-001	Mar 8, 2017		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Exela Pharma Scs Llc	GLYRX-PF	glycopyrrolate	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	210997-002	Jul 11, 2018		RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Scs Llc	MAGNESIUM SULFATE	magnesium sulfate	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	206039-001	Dec 18, 2014	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Scs Llc	GANCICLOVIR	ganciclovir	SOLUTION;IV (INFUSION)	209347-001	Feb 17, 2017		RX	Yes	Yes	9,486,530	➤ Sign Up	Y			➤ Sign Up
Exela Pharma Scs Llc	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	SOLUTION;INTRAVENOUS	018925-001	Mar 30, 1984	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Scs Llc	NIPRIDE RTU IN SODIUM CHLORIDE 0.9%	sodium nitroprusside	SOLUTION;INTRAVENOUS	209387-003	Jul 13, 2018		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald

Citi

Mallinckrodt

Harvard Business School

US Army

Healthtrust

Queensland Health

McKesson

QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.